Translational Immunology

Translational immunology is the process by which researchers apply immunological discoveries and provide practical solutions to human problems. Vaccine development against infectious diseases is one example, as is the creation of novel types of medications to treat inflammatory conditions.

The series' goal is to enhance knowledge and provide updates on current topics in immunology; specifically, the series aims to translate study results and recent findings into clinical practice.

The series, written and edited by leading international scientists, is aimed primarily at graduate-level immunologists, clinicians, and students, as well as individuals working in academic, corporate, or non-profit settings. Its ethical goal is to encourage worldwide benefit sharing of immunological advancements through the publication of foundational, consensus-building content.

The translational immunology series seeks to provide comprehensive coverage of the Network of immunity in infection, malignancy, and autoimmunity (NIIMA), which is one of the primary fields of science without borders in the universal scientific education and research network (USERN). Autoimmunity, allergy, infection and immunity, inborn immunity errors, immunodeficiencies, AIDS, immunopharmacology, transplantation, cancer immunology, immunotherapy, neuroimmunology, vaccination are examples of possible Series Volume topics.

+1 (506) 909-0537